A case report of peritoneal dialysis–associated peritonitis caused by Mycobacterium mageritense

IF 1.5 Q4 INFECTIOUS DISEASES
Kazuhiro Ishikawa , Nozomi Kadota , Masaaki Nakayama , Nobuyoshi Mori
{"title":"A case report of peritoneal dialysis–associated peritonitis caused by Mycobacterium mageritense","authors":"Kazuhiro Ishikawa ,&nbsp;Nozomi Kadota ,&nbsp;Masaaki Nakayama ,&nbsp;Nobuyoshi Mori","doi":"10.1016/j.ijregi.2025.100659","DOIUrl":null,"url":null,"abstract":"<div><div>Non-tuberculous mycobacteria can result in peritoneal dialysis (PD)–associated peritonitis and PD catheter–related infections, including tunnel and exit site infection. We report the case of a 78-year-old male patient undergoing PD for end-stage renal failure due to diabetic nephropathy, with a medical history that includes PD catheter–related infections. He developed <em>Mycobacgerium mageritense</em> peritonitis secondary to a PD catheter–related infection. <em>M. mageritense</em> grew on blood agar, and its identification was confirmed using matrix-assisted laser desorption ionization-time of flight/mass spectrometer (MALDI-TOF/MS) and 16S rRNA sequencing. Based on susceptibility testing, treatment was initiated with trimethoprim/sulfamethoxazole (TMP/SMX) (80 mg/400 mg) 5 mg/kg every 24 hours in combination with minocycline 100 mg every 12 hours, which was subsequently changed to TMP/SMX plus faropenem 200 mg every 8 hours due to nausea caused by minocycline. However, the antimicrobial therapy proved to be ineffective, and the patient subsequently developed complicated PD-associated peritonitis, leading to the removal of the PD catheter. We switched to TMP/SMX, imipenem/cilastatin 500 mg every 12 hours, and used linezolid 600 mg every 12 hours, which was later replaced with amikacin, guided by therapeutic drug monitoring. Subsequent complications related to antimicrobial therapy included nausea caused by linezolid and hearing impairment due to amikacin. We treated the patient with TMP/SMX and sitafloxacin 100 mg every 24 hours, which was well-tolerated. The patient was treated for 18 months without a relapse. Our findings underscore the importance of suspecting non-tuberculous mycobacteria in PD catheter–related infection and considering the early inclusion of acid-fast bacillus culture. Given the diagnostic challenges and the complexity of managing multi-drug antimicrobial therapy in patients with renal dysfunction, we recommend early catheter removal.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"15 ","pages":"Article 100659"},"PeriodicalIF":1.5000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJID regions","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772707625000943","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Non-tuberculous mycobacteria can result in peritoneal dialysis (PD)–associated peritonitis and PD catheter–related infections, including tunnel and exit site infection. We report the case of a 78-year-old male patient undergoing PD for end-stage renal failure due to diabetic nephropathy, with a medical history that includes PD catheter–related infections. He developed Mycobacgerium mageritense peritonitis secondary to a PD catheter–related infection. M. mageritense grew on blood agar, and its identification was confirmed using matrix-assisted laser desorption ionization-time of flight/mass spectrometer (MALDI-TOF/MS) and 16S rRNA sequencing. Based on susceptibility testing, treatment was initiated with trimethoprim/sulfamethoxazole (TMP/SMX) (80 mg/400 mg) 5 mg/kg every 24 hours in combination with minocycline 100 mg every 12 hours, which was subsequently changed to TMP/SMX plus faropenem 200 mg every 8 hours due to nausea caused by minocycline. However, the antimicrobial therapy proved to be ineffective, and the patient subsequently developed complicated PD-associated peritonitis, leading to the removal of the PD catheter. We switched to TMP/SMX, imipenem/cilastatin 500 mg every 12 hours, and used linezolid 600 mg every 12 hours, which was later replaced with amikacin, guided by therapeutic drug monitoring. Subsequent complications related to antimicrobial therapy included nausea caused by linezolid and hearing impairment due to amikacin. We treated the patient with TMP/SMX and sitafloxacin 100 mg every 24 hours, which was well-tolerated. The patient was treated for 18 months without a relapse. Our findings underscore the importance of suspecting non-tuberculous mycobacteria in PD catheter–related infection and considering the early inclusion of acid-fast bacillus culture. Given the diagnostic challenges and the complexity of managing multi-drug antimicrobial therapy in patients with renal dysfunction, we recommend early catheter removal.
马氏分枝杆菌所致腹膜透析相关性腹膜炎1例
非结核分枝杆菌可导致腹膜透析(PD)相关腹膜炎和PD导管相关感染,包括隧道和出口部位感染。我们报告一例78岁男性患者,因糖尿病肾病导致终末期肾衰竭而接受PD治疗,其病史包括PD导管相关感染。他继发于PD导管相关感染的马氏分枝杆菌腹膜炎。利用基质辅助激光解吸电离飞行时间/质谱仪(MALDI-TOF/MS)和16S rRNA测序对其进行了鉴定。根据药敏试验,开始治疗时使用甲氧苄啶/磺胺甲恶唑(TMP/SMX) (80 mg/400 mg) 5 mg/kg / 24小时联合米诺环素100 mg/ 12小时,随后由于米诺环素引起恶心,改为TMP/SMX加法罗培南200 mg/ 8小时。然而,抗菌治疗被证明是无效的,患者随后发生了复杂的PD相关性腹膜炎,导致PD导管被切除。我们改用TMP/SMX,亚胺培南/西司他汀500 mg / 12小时,利奈唑胺600 mg / 12小时,随后在治疗药物监测指导下改为阿米卡星。随后与抗菌药物治疗相关的并发症包括利奈唑胺引起的恶心和阿米卡星引起的听力损害。我们给予TMP/SMX联合西他沙星100 mg / 24小时治疗,患者耐受性良好。患者治疗18个月无复发。我们的研究结果强调了在PD导管相关感染中怀疑非结核分枝杆菌的重要性,并考虑早期纳入抗酸杆菌培养。考虑到诊断的挑战和管理多药抗菌药物治疗肾功能不全患者的复杂性,我们建议早期拔管。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
IJID regions
IJID regions Infectious Diseases
CiteScore
1.60
自引率
0.00%
发文量
0
审稿时长
64 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信